CRMD Stock Summary and Trading Ideas (Cormedix | NASDAQ:CRMD)

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.

Cormedix trades on the NASDAQ stock market under the symbol CRMD.

As of May 16, 2024, CRMD stock price declined to $5.20 with 461,881 million shares trading.

CRMD has a beta of 0.82, meaning it tends to be less sensitive to market movements. CRMD has a correlation of 0.02 to the broad based SPY ETF.

CRMD has a market cap of $285.90 million. This is considered a Small Cap stock.

In the last 3 years, CRMD stock traded as high as $8.38 and as low as $2.57.

The top ETF exchange traded funds that CRMD belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

CRMD has underperformed the market in the last year with a price return of +1.0% while the SPY ETF gained +29.6%. However, in the short term, CRMD had mixed performance relative to the market. It has outperformed in the last 3 months, returning +59.0% vs +5.6% return in SPY. But in the last 2 weeks, CRMD shares have been beat by the market, returning -5.8% compared to an SPY return of +5.7%.

CRMD support price is $5.00 and resistance is $5.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CRMD stock will trade within this expected range on the day.